Home-based palliative approach for people with severe multiple sclerosis and their carers (PeNSAMI): where we are, where we are going

被引：0

作者：

Giordano, A. ^{[1
]}

Borreani, C. ^{[2
]}

Grasso, M. G. ^{[3
]}

Confalonieri, P. ^{[1
]}

Patti, F. ^{[4
]}

Lugaresi, A. ^{[5
]}

Palmisano, L. ^{[6
]}

Amadeo, R. ^{[7
]}

Martino, G. ^{[7
]}

Ponzio, M. ^{[7
]}

Causarano, R. ^{[8
]}

Casale, G. ^{[9
]}

Veronese, S. ^{[10
]}

Zaratin, P. ^{[7
]}

Battaglia, M. A. ^{[7
]}

Solari, A. ^{[1
]}

机构：

[1] Fdn IRCCS Neurol Inst C Besta, Milan, Italy

[2] Fdn IRCCS Ist Nazl Cura Tumori, Unit Psychol, Milan, Italy

[3] Fdn IRCCS S Lucia Rehabil Hosp, Multiple Sclerosis Unit, Rome, Italy

[4] Univ Hosp Policlin Vittorio Emanuele, MS Ctr, Neurol Clin, Catania, Italy

[5] G DAnnunzio Univ Chieti Pescara, Dept Neurosci Imaging & Clin Sci, Chieti, Italy

[6] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy

[7] Fdn Italiana Sclerosi Multipla, Assoc Italiana Sclerosi Multipla, Genoa, Italy

[8] Osped Niguarda Ca Granda, Unit Palliat Care Hosp, Milan, Italy

[9] Antea Assoc Onlus, Rome, Italy

[10] FARO Fdn Onlus, Turin, Italy

来源：

MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：506 / 507

页数：2

共 50 条

[41] Drug prevention programmes for young people: where have we been and where should we be going?
Midford, Richard
ADDICTION, 2010, 105 (10) : 1688 - 1695
[42] Treatment of Severe Genetic Dyslipidemia: Where Are We Going?
Stefanutti, Claudia
THERAPEUTIC APHERESIS AND DIALYSIS, 2013, 17 (02) : 122 - 123
[43] Multiple sclerosis in Kashmir: Where we stand
Zahoor, Insha
Haq, Ehtishamul
Asimi, Ravouf
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 373 : 129 - 133
[44] Therapeutic Approaches toward Multiple Sclerosis: Where Do We Stand and Where Are We Headed?
Moura, Rui Pedro
Sarmento, Bruno
ADVANCED THERAPEUTICS, 2019, 2 (10)
[45] Plant-based vaccines and cancer therapy: Where are we now and where are we going?
Rahimian, Neda
Miraei, Hamid Reza
Amiri, Atefeh
Ebrahimi, Mohammad Saeid
Nahand, Javid Sadri
Tarrahimofrad, Hossein
Hamblin, Michael R.
Khan, Haroon
Mirzaei, Hamed
PHARMACOLOGICAL RESEARCH, 2021, 169
[46] Cognitive and Psychosocial Issues in Pediatric Multiple Sclerosis: Where We Are and Where We Need To Go
Amato, Maria Pia
NEUROPEDIATRICS, 2012, 43 (04) : 174 - 175
[47] Where Are We Going with Autologous Transplantation for Multiple Myeloma?
McCarthy, Philip L.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (11) : 1532 - 1533
[48] Where are we, and where are we going, with DNA-based approaches in immunohematology? Is serology finished?
Garratty, George
TRANSFUSION, 2007, 47 (01) : 1S - 2S
[49] Back to the future: home-based primary care for older homebound Canadians Part 2: where we are going
Stall, Nathan
Nowaczynski, Mark
Sinha, Samir K.
CANADIAN FAMILY PHYSICIAN, 2013, 59 (03) : 243 - 245
[50] ASO Author Reflections: Multiple Ipsilateral Breast Cancer: Where Have We Been, Where are We Going
Rosenkranz, Kari M.
Boughey, Judy C.
ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (Suppl 3) : 686 - 687

← 1 2 3 4 5 →